Exenatide and Dapagliflozin Combination Enhances Sertoli Cell Secretion of Key Metabolites for Spermatogenesis.

Ribeiro, João C; Martins, Ana D; Jarak, Ivana; Carvalho, Rui A; Alves, Marco G; Oliveira, Pedro F

Ribeiro, João C; Martins, Ana D; Jarak, Ivana; Carvalho, Rui A; Alves, Marco G; Oliveira, Pedro F.

Afiliación

Ribeiro JC; Departamento de Anatomia, UMIB-Unidade Multidisciplinar de Investigação Biomédica, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.
Martins AD; Laboratory for Integrative and Translational Research in Population Health (ITR), University of Porto, 4050-600 Porto, Portugal.
Jarak I; LAQV, Department of Chemistry, University of Aveiro, 3810-193 Aveiro, Portugal.
Carvalho RA; Departamento de Anatomia, UMIB-Unidade Multidisciplinar de Investigação Biomédica, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal.
Alves MG; Department of Pharmaceutical Technology, Faculty of Pharmacy, Azinhaga de Santa Comba, University of Coimbra, Pólo III-Pólo das Ciências da Saúde, 3000-548 Coimbra, Portugal.
Oliveira PF; Department of Life Sciences, Faculty of Sciences and Technology, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal.

Biomedicines ; 10(5)2022 May 11.

Article en En | MEDLINE | ID: mdl-35625851

Palabras clave

Sertoli cells; dapagliflozin; diabetes mellitus; exenatide; spermatogenesis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Biomedicines Año: 2022 Tipo del documento: Article País de afiliación: Portugal Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google